Rigel Pharmaceuticals RIGL
$ 27.28
9.32%
Quarterly report 2024-Q3
added 11-07-2024
Country |
USA |
IPO year |
2000 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Raul Rodriguez |
Employees in the company |
163 |
Shares |
174 M |
Market Cap[1] |
$ 4.75 B |
EBITDA (LTM) |
$ 4.97 M |
P/E (LTM) |
57.81 |
P/S (LTM) |
18.13 |
EPS (LTM) |
0.27 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.